Cite
HARVARD Citation
Ji, L. et al. (2017). Efficacy and safety of fixed‐dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial. Diabetes, obesity & metabolism. 19 (5), pp. 754-758. [Online].